title: Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project.
abstract: Vitamin supplement use after breast cancer diagnosis is common, but little is known about long-term effects on recurrence and survival. We examined postdiagnosis supplement use and risk of death or recurrence in the After Breast Cancer Pooling Project, a consortium of four cohorts of 12,019 breast cancer survivors from the United States and China. Post-treatment supplement use (vitamins A, B, C, D, E, and multivitamins) was assessed 1-5 years postdiagnosis. Associations with risk of recurrence, breast cancer-specific mortality, or total mortality were analyzed in Cox proportional hazards models separately by cohort. Individual cohort results were combined using random effects meta-analysis. Interactions with smoking, treatment, and hormonal status were examined. In multivariate models, vitamin E was associated with a decreased risk of recurrence (RR: 0.88; 95 % CI 0.79-0.99), and vitamin C with decreased risk of death (RR: 0.81; 95 % CI 0.72-0.92). However, when supplements were mutually adjusted, all associations were attenuated. There were no statistically significant associations with breast cancer mortality. The use of antioxidant supplements (multivitamins, vitamin C, or E) was not associated with recurrence, but was associated with a 16 % decreased risk of death (95 % CI 0.72-0.99). In addition, vitamin D was associated with decreased risk of recurrence among ER positive, but not ER negative tumors (p-interaction = 0.01). In this large consortium of breast cancer survivors, post-treatment use of vitamin supplements was not associated with increased risk of recurrence or death. Post-treatment use of antioxidant supplements was associated with improved survival, but the associations with individual supplement were difficult to determine. Stratification by ER status and considering antioxidants as a group may be more clinically relevant when evaluating associations with cancer risk and mortality.
authors: Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. nhlip@channing.harvard.edu
authors: Elizabeth M
authors: EM
authors: Poole
authors: XiaoOu
authors: X
authors: Shu
authors: Bette J
authors: BJ
authors: Caan
authors: Shirley W
authors: SW
authors: Flatt
authors: Michelle D
authors: MD
authors: Holmes
authors: Wei
authors: W
authors: Lu
authors: Marilyn L
authors: ML
authors: Kwan
authors: Sarah J
authors: SJ
authors: Nechuta
authors: John P
authors: JP
authors: Pierce
authors: Wendy Y
authors: WY
authors: Chen
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors; D017741:Survivors
chemical_list: D014408:Biomarkers, Tumor
references: PLoS One. 2011 Feb 28;6(2):e17251
references: 21386992
references: JAMA. 2009 Dec 9;302(22):2437-43
references: 19996398
references: Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):582-93
references: 22278364
references: J Natl Cancer Inst. 2008 Jun 4;100(11):773-83
references: 18505970
references: Nutr Cancer. 2002;44(2):139-44
references: 12734059
references: Hematology. 2011 Sep;16(5):278-83
references: 21902891
references: Nutr Cancer. 2003;46(1):15-22
references: 12925299
references: Am J Epidemiol. 2006 Jun 1;163(11):1053-64
references: 16624970
references: J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):405-12
references: 21684333
references: Br J Cancer. 2009 Sep 15;101(6):916-23
references: 19690551
references: Int J Cancer. 2011 Mar 1;128(5):1169-78
references: 20473915
references: JAMA. 2007 Jul 18;298(3):289-98
references: 17635889
references: J Clin Oncol. 2008 Jun 20;26(18):2984-91
references: 18565885
references: Control Clin Trials. 1986 Sep;7(3):177-88
references: 3802833
references: Cancer Causes Control. 2011 Sep;22(9):1319-31
references: 21710192
references: Obesity (Silver Spring). 2012 Nov;20(11):2296-301
references: 22402737
references: J Clin Oncol. 2009 May 1;27(13):2117-9
references: 19349538
references: Am J Clin Nutr. 2011 Dec;94(6):1471-8
references: 22030222
references: Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):262-71
references: 21177425
references: Ann Surg Oncol. 2012 Aug;19(8):2590-9
references: 22446898
references: Cancer. 2012 Apr 15;118(8):2048-58
references: 21953120
references: Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2109-16
references: 18708404
references: Cancer Causes Control. 2005 Jun;16(5):545-56
references: 15986109
references: N Engl J Med. 1996 May 2;334(18):1150-5
references: 8602180
references: J Transl Med. 2012 Jan 27;10:16
references: 22284859
references: J Clin Endocrinol Metab. 2012 Feb;97(2):614-22
references: 22112804
references: N Engl J Med. 1994 Apr 14;330(15):1029-35
references: 8127329
references: Nat Rev Cancer. 2005 May;5(5):388-96
references: 15864280
references: Cancer. 2009 Jul 15;115(14):3271-82
references: 19507173
references: Int J Cancer. 2008 Apr 1;122(7):1679-83
references: 18059031
references: Int J Cancer. 2011 Apr 1;128(7):1741-6
references: 20533282
references: J Clin Oncol. 2010 Sep 10;28(26):4081-5
references: 20697066
references: Breast Cancer Res Treat. 2011 Nov;130(1):195-205
references: 21559824
references: Nutr Cancer. 2011;63(3):327-33
references: 21391124